Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04956887 · ClinicalTrials.gov registry record · NA
Cognitive Training in Survivors of Covid-19: A Randomized Trial
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT04956887 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 83 participants.
The verdict
NCT04956887, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Preliminary evidence suggests that cognitive impairment is a common outcome experienced by individuals surviving Covid-19 (1-5). Cognitive impairment following Covid-19 which leads to critical illness is not surprising and perhaps even expected. However, significant cognitive deficits appear to be common even among individuals testing positive for Covid-19 who were never hospitalized. Questions exist regarding the mechanisms of the aforementioned cognitive impairment. The association between COVID-19 and brain dysfunction is not surprising since SARS-CoV has been found in the brain and because Coronaviridaes (CoVs) have been associated with central nervous system (CNS) diseases such as acute viral encephalopathy, acute disseminated encephalomyelitis, and multiple sclerosis (6-11).The possible brain entry routes for CoVs include either direct intranasal access to the brain via olfactory nerves or indirect access by crossing the blood-brain barrier (BBB) via hematogenous or lymphatic spread (9).
Interventions
- OTHER Control Group
- BEHAVIORAL AKL-T01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-08-03 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04956887
The ClinicalTrials.gov registry entry for NCT04956887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT04956887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04956887 about?
NCT04956887 is a clinical study titled "Cognitive Training in Survivors of Covid-19: A Randomized Trial". Preliminary evidence suggests that cognitive impairment is a common outcome experienced by individuals surviving Covid-19 (1-5). Cognitive impairment following Covid-19 which leads to critical illness is not surprising and perhaps even expected. However, significant cognitive deficits appear to be c...
What is the current status of trial NCT04956887?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2021-08-03. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04956887?
The interventions under investigation include: Control Group (OTHER), AKL-T01 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04956887?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.